Invesaro

Stocks VIR Earnings

Earnings

Vir Biotechnology, Inc. (VIR) earnings

Quarterly results of Vir Biotechnology, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when VIR files with the SEC.

Next earnings date

Vir Biotechnology, Inc. is expected to report around January 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Vir Biotechnology, Inc. reported revenue of $188K and a net loss of $96.3M.

Diluted earnings per share were -$0.57.

Filed with the SEC on November 4, 2026.

Revenue by quarter
Q4 24: $12.4M $12.4M Q4 24Q1 25: $3M $3M Q1 25Q2 25: $1.2M $1.2M Q2 25Q3 25: $240K $240K Q3 25Q4 25: $64.1M $64.1M Q4 25Q1 26: -$29K -$29K Q1 26Q2 26: $238.9M $238.9M Q2 26Q3 26: -$188K -$188K Q3 26
Net income by quarter
Q4 24: -$104.6M -$104.6M Q4 24Q1 25: -$121M -$121M Q1 25Q2 25: -$111M -$111M Q2 25Q3 25: -$163.1M -$163.1M Q3 25Q4 25: -$42.9M -$42.9M Q4 25Q1 26: -$125.7M -$125.7M Q1 26Q2 26: $80.1M $80.1M Q2 26Q3 26: -$96.3M -$96.3M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026-$188K--$96.3M-$0.57
Q2 FY2026June 30, 2026$238.9M+19,582.5%$80.1M$0.47
Q1 FY2026March 31, 2026-$29K--$125.7M-$0.85
Q4 FY2025December 31, 2025$64.1M+417.8%-$42.9M-
Q3 FY2025September 30, 2025$240K--$163.1M-$1.17
Q2 FY2025June 30, 2025$1.2M--$111M-$0.80
Q1 FY2025March 31, 2025$3M--$121M-$0.88
Q4 FY2024December 31, 2024$12.4M--$104.6M-

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Vir Biotechnology, Inc.'s next earnings date?

Vir Biotechnology, Inc. is expected to report around January 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Vir Biotechnology, Inc.'s latest quarterly results?

For Q3 FY2026, which ended September 30, 2026, Vir Biotechnology, Inc. reported revenue of $188K and a net loss of $96.3M. The figures come from its filing with the SEC.

Get an email when VIR reports

Follow VIR and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when VIR files with the SEC.

Source: quarterly figures Vir Biotechnology, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Vir Biotechnology, Inc.